PAPPA and Down syndrome: PAPP-A combined with maternal age, nuchal translucency, and beta human chorionic gonadotropin (HCG) provides high detection rates for Down syndrome of up to 60% - 85% for combined first trimester prenatal screening (and up to 94% with the addition of inhibin A) with only a 5% false-positive rate [1, 49-50].